Reclast, the first once-a-YEAR bisphosphonate for treating postmenopausal osteoporosis

September 2007

View FDA's preliminary statement concerning bisphosphonates and atrial fibrillation

Women will be hearing about Reclast, the first once-a-YEAR bisphosphonate for treating postmenopausal osteoporosis.

It can be given as a 15-minute infusion in a doctor's office.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

More patients will be getting vaccines for meningitis, hepatitis A, varicella, pertussis, and influenza
Osteoporosis Reclast, the first once-a-YEAR bisphosphonate for treating postmenopausal osteoporosis
Dermatology Some Daytrana (methylphenidate) patches are falling off
Infectious Diseases new HIV drug, Selzentry (maraviroc)
Gastroenterology Prilosec and Nexium might cause heart problems
Gastroenterology Zelnorm (tegaserod) is back, but only for certain patients
Geriatrics misuse of the Beers criteria to determine drug therapy in the elderly
Psychiatry Exelon (rivastigmine) now comes in a once-daily PATCH
Ophthalmology eyedrop called AzaSite for bacterial conjunctivitis or "pink eye"
Respiratory & Allergy new Rx antihistamine called Xyzal (ZEYE-zol)
Respiratory & Allergy Zyflo CR, a new extended-release version of zileuton for chronic asthma
Diabetes whether patients with type 2 diabetes benefit from monitoring their blood glucose
Diabetes how to treat diabetes during pregnancy
new requirement to use tamper-resistant pads for most written Medicaid prescriptions